4.6 Review

Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial

Olivia J. Hofer et al.

Summary: This study aimed to determine whether there were differences in maternal, infant, and childhood health outcomes between the use of dexamethasone or betamethasone as a repeat antenatal corticosteroid for women at risk of preterm birth after an initial course. The results showed that there were no significant differences in health outcomes between the two groups.

PLOS ONE (2022)

Article Obstetrics & Gynecology

Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial

Nuraini Sukarna et al.

Summary: The study compared two different doses of dexamethasone in the treatment of gestational diabetes, showing fewer hyperglycemic episodes on the second day with the 12-mg dose, suggesting that the 12-mg dose regimen may be preferable.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)

Article Obstetrics & Gynecology

Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial

Olivia J. Hofer et al.

Summary: This study found no significant association between maternal body mass index and infant morbidity after the administration of antenatal corticosteroids, indicating that dose adjustment for overweight or obese women is not necessary to reduce infant morbidity.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2021)

Article Obstetrics & Gynecology

LB03 Dose reduction of antenatal betamethasone in women at risk of very preterm delivery (BETADOSE trial)

Thomas Schmitz et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Article Obstetrics & Gynecology

FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm

Jane Norman et al.

Summary: For women with singleton or multiple pregnancies between 24 and 34 weeks gestation where active neonatal care is necessary, one course of prenatal corticosteroids should be offered ideally 18 to 72 hours before anticipated preterm birth to improve outcomes for the baby. Prenatal corticosteroids should not be routinely offered to women anticipating late preterm birth between 34 and 36 weeks.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)

Article Obstetrics & Gynecology

Short-Term Effects of Dexamethasone versus Betamethasone on Ultrasonic Measures of Fetal Well-Being: Cohort from a Blinded, Randomized Trial

Amanda Henry et al.

Summary: In fetuses with heightened risk of preterm birth but normal pre-corticosteroid measures, most ultrasound/CTG measures did not show substantive effects post-corticosteroid treatment. This suggests the importance of not relying solely on individual measures for delivery decisions post-corticosteroid, as well as emphasizing that significant ultrasound changes may indicate true pathology rather than steroid effects.

FETAL DIAGNOSIS AND THERAPY (2021)

Review Obstetrics & Gynecology

Dexamethasone versus betamethasone for preterm birth: a systematic review and network meta-analysis

Agustin Ciapponi et al.

Summary: This study evaluated the clinical effectiveness and safety of dexamethasone vs betamethasone for preterm birth. No significant difference was found between the two drugs in neonatal death, neurodevelopmental disability, intraventricular hemorrhage, and birthweight, but potential important differences were found in other outcomes such as chorioamnionitis and respiratory distress syndrome.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Review Pediatrics

Antenatal corticosteroids: a reappraisal of the drug formulation and dose

Alan H. Jobe et al.

Summary: The history of antenatal corticosteroid therapy is reviewed, indicating inadequate evaluation and the need to minimize fetal exposure to medications. Recent experimental data show the importance of reducing fetal drug exposure to optimize outcomes. Studies suggest that the current dosing of corticosteroids may exceed the minimum exposure needed for fetal lung maturation.

PEDIATRIC RESEARCH (2021)

Review Medicine, General & Internal

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

Emma McGoldrick et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Public, Environmental & Occupational Health

Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis

Saifon Chawanpaiboon et al.

LANCET GLOBAL HEALTH (2019)

Article Obstetrics & Gynecology

Short- and Long-Term Outcomes for Extremely Preterm Infants

Ravi Mangal Patel

AMERICAN JOURNAL OF PERINATOLOGY (2016)

Review Medicine, General & Internal

Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes

Caroline A. Crowther et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)

Article Obstetrics & Gynecology

Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes

Ewa Romejko-Wolniewicz et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)

Review Medicine, General & Internal

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth

Fiona C. Brownfoot et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

Meeting Abstract Obstetrics & Gynecology

Betamethasone dosing interval-12 or 24 hours apart?

Meena Khandelwal et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)

Article Obstetrics & Gynecology

Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial

Meena Khandelwal et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)

Article Obstetrics & Gynecology

Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles

Anthony Shanks et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)

Meeting Abstract Obstetrics & Gynecology

ANTENATAL STEROIDS FOR ENHANCEMENT OF FETAL LUNG MATURITY AFTER 34 WEEKS: LUNG MATURITY AND ANTENATAL STEROIDS (LUMAS) STUDY

Anthony Shanks et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)

Review Medicine, General & Internal

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth

Fiona C. Brownfoot et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)

Article Health Care Sciences & Services

Optimising reproductive and child health outcomes by building evidence-based research and practice in South East Asia (SEA-ORCHID): study protocol

David J. Henderson-Smart et al.

BMC MEDICAL RESEARCH METHODOLOGY (2007)

Article Obstetrics & Gynecology

Antenatal betamethasone compared with dexamethasone (betacode trial) - A randomized controlled trial

Andrew Elimian et al.

OBSTETRICS AND GYNECOLOGY (2007)

Meeting Abstract Obstetrics & Gynecology

Betacode trial antenatal betamethasone compared to dexamethasone: A randomized controlled trial

A Elimian et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)

Article Obstetrics & Gynecology

Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms

R Urban et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)

Article Obstetrics & Gynecology

Choice and dose of corticosteroid for antenatal treatments

AH Jobe et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)

Review Obstetrics & Gynecology

Preterm delivery: an overview

K Haram et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)

Article Obstetrics & Gynecology

The effect of betamethasone versus dexamethasone on fetal biophysical parameters

Y Mushkat et al.

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)